0 items
Your cart is empty.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
$162.00
This product is available by prescription only
This product does not require a prescription
Out Of Stock
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
This synthetic research tripeptide formulation provides laboratories with a standardized bioregulator compound for experimental studies. The higher-quantity 50mg format supports extensive research applications and multiple experimental protocols. Each batch undergoes rigorous purity verification to ensure consistency across research series. High-purity formulation meets research-grade standards for tripeptide bioregulator investigations. Secure packaging protects compound integrity during storage and transport. Discreet shipment ensures confidential delivery to research facilities and institutional laboratories.
Researchers investigate Vesugen tripeptide within controlled laboratory environments to examine bioregulator peptide mechanisms. Experimental models utilize this compound to study tripeptide interactions in vitro. Controlled laboratory peptide stability studies assess compound properties under standardized experimental conditions. Scientists explore structural characteristics of short-chain bioregulator peptides in research settings. Laboratory personnel examine tripeptide behavior in experimental models designed for bioregulator research. These investigations occur exclusively in controlled research environments without clinical applications.
Vesugen tripeptide is investigated in research environments to understand bioregulator peptide mechanisms. This compound is studied within controlled laboratory models examining tripeptide properties. Researchers explore this peptide for experimental peptide research applications in academic and institutional settings. Laboratory studies examine the compound’s molecular characteristics under standardized protocols. Scientists investigate structural properties relevant to bioregulator peptide research methodologies. All research applications remain confined to laboratory environments and experimental frameworks.
Store Vesugen peptide in cool, dry conditions protected from light exposure. Storage temperature should remain consistent to maintain compound stability. Keep the product sealed until ready for laboratory use. Laboratory handling should occur only by qualified research personnel trained in peptide research protocols. Avoid exposure to moisture, heat, and direct sunlight during storage. Use appropriate laboratory equipment when handling this research compound. Reconstitution should follow standard laboratory peptide preparation procedures using sterile techniques. Maintain proper documentation of handling and storage conditions for research records. Dispose of unused material according to institutional laboratory waste protocols.
Each batch undergoes comprehensive purity verification procedures to confirm research-grade quality. Third-party testing validates compound purity at 99%+ by HPLC analysis. Batch-to-batch consistency ensures reliable results across research protocols. Certificate of Analysis accompanies each order documenting purity verification results. Internal quality assurance standards maintain strict compound specifications. Testing procedures verify molecular weight, purity percentage, and compound identity. Research-grade supply positioning ensures suitability for controlled laboratory investigations. Quality control documentation supports institutional research compliance requirements.
Vesugen is a synthetic tripeptide bioregulator produced for research applications. A tripeptide is a peptide consisting of three amino acids linked together. Bioregulator peptides are short-chain peptides studied for their molecular properties in experimental models. This specific sequence contains lysine, glutamic acid, and aspartic acid amino acids. These short peptides are investigated to understand how minimal amino acid sequences function at the molecular level. This synthetic peptide origin ensures batch-to-batch consistency for research protocols. The compound represents a defined three-amino-acid sequence for experimental investigation. Researchers examine this tripeptide’s properties within controlled laboratory conditions without therapeutic context.
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
High-purity, research-grade peptide synthesis
Analytical testing to verify quality and composition
Consistent batch-to-batch performance
Batch identification on every vial for traceability
Stored and shipped under controlled conditions
Research-grade synthetic thymic peptide formulated in 10mg quantity for immune peptide studies and thymosin mechanism research in controlled laboratory environments.
Research-grade decapeptide signaling molecule formulated for experimental peptide pathway research in controlled laboratory environments.
Research-grade dual-peptide blend combining short-acting synthetic peptides for flexible laboratory research protocols.
Research-grade dual GIP/GLP-1 peptide by NOVERA, USA-made, 99% purity, for advanced metabolic studies.
